Cellular Biomedicine Group Chooses Rockville, Maryland, R&D Cancer Immunotherapies Center
10/04/2019
The Rockville campus will augment its global research and development capabilities and to support clinical trials in the United States centering around both its liquid tumor and solid tumor candidates.
According to company officials, the Rockville facility is strategically located in the heart of Maryland's life sciences center, on Medical Center Drive, an area commonly referred to as "DNA Alley."
The facility, when completed, will allow the development of new technology and preparation for clinical trials according to U.S. Food and Drug Administration (FDA) guidelines. The company intends for the facility to have a capacity to accommodate early phases of CBMG's clinical trials for its liquid and solid tumor candidates.
"This new site is poised to foster strategic partnership, new innovations, and support the continued development of CBMG's cell therapy based immune-oncology assets in the US that have showed promise in early proof-of-concept trials," said Tony (Bizuo) Liu, CEO for the Company.
Cellular Biomedicine Group, Inc. conducts immuno-oncology and stem cell clinical trials in China using products from its integrated GMP laboratory. The Company's GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards.
Project Announcements
Swiss-Based GF Casting Solutions AG Plans Augusta, Georgia, Operations
05/07/2024
3M Expands Valley, Nebraska, Production Operations
05/07/2024
Advanced Call Center Technologies Expands Norman, Oklahoma, Operations
05/07/2024
Rivian Automotive Expands Normal, Illinois, Operations
05/06/2024
Meta Platforms Plans Montgomery, Alabama, Data Center Operations
05/06/2024
Crystal Window & Door Systems Plans Selma, North Carolina, Production Operations
05/06/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
Making Hybrid More Human in 2024
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
Last Word: Striking a Balance - Prioritizing Electric Infrastructure While Preparing for the Next Wave of Industrial Expansion
Q1 2024